Remission of inflammatory arthropathy in association with anti-CD20 therapy for non-Hodgkin's lymphoma.
We describe a case involving a 53-yr-old male with a marginal zone B-cell lymphoma, associated with an IgM paraprotein and a rheumatoid factor-negative inflammatory polyarthropathy, treated with monoclonal anti-CD20 antibody. During the subsequent 12 weeks, evidence of synovitis reduced to a negligible level, despite no significant change in lymphoma bulk or paraprotein level. The relationship between the lymphoma and the arthropathy, and the likely mechanism of remission of the arthropathy, are discussed in the context of the potential value of anti-CD20 therapy in rheumatoid arthritis.
Protheroe
A
A
ICRF Cancer Medicine Research Unit, St James' University Hospital, Leeds, UK.
Edwards
J C
JC
Simmons
A
A
Maclennan
K
K
Selby
P
P
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018951:Antigens, CD20 / Q000276:immunology*; D001168:Arthritis / Q000209:etiology* / Q000628:therapy; D006801:Humans; D007167:Immunotherapy; D016393:Lymphoma, B-Cell / Q000150:complications* / Q000276:immunology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010266:Paraproteins / Q000378:metabolism; D012074:Remission Induction
D000911:Antibodies, Monoclonal; D018951:Antigens, CD20; D010266:Paraproteins